Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Real Estate - GrossReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Immutep (PRRUF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Immutep (PRRUF) over the last 12 years, with Q2 2025 value amounting to $43.2 million.

  • Immutep's Cash & Equivalents fell 5951.14% to $43.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $43.2 million, marking a year-over-year decrease of 5951.14%. This contributed to the annual value of $43.2 million for FY2025, which is 5951.14% down from last year.
  • Per Immutep's latest filing, its Cash & Equivalents stood at $43.2 million for Q2 2025, which was down 5951.14% from $48.3 million recorded in Q4 2024.
  • Over the past 5 years, Immutep's Cash & Equivalents peaked at $106.6 million during Q2 2024, and registered a low of $43.2 million during Q2 2025.
  • Its 5-year average for Cash & Equivalents is $63.3 million, with a median of $57.3 million in 2022.
  • In the last 5 years, Immutep's Cash & Equivalents soared by 17046.18% in 2021 and then plummeted by 5951.14% in 2025.
  • Quarter analysis of 5 years shows Immutep's Cash & Equivalents stood at $72.6 million in 2021, then crashed by 38.12% to $44.9 million in 2022, then skyrocketed by 50.32% to $67.5 million in 2023, then decreased by 28.45% to $48.3 million in 2024, then dropped by 10.65% to $43.2 million in 2025.
  • Its last three reported values are $43.2 million in Q2 2025, $48.3 million for Q4 2024, and $106.6 million during Q2 2024.